BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38403231)

  • 1. Review: Protein O-GlcNAcylation regulates DNA damage response: A novel target for cancer therapy.
    Zhu Z; Li S; Yin X; Sun K; Song J; Ren W; Gao L; Zhi K
    Int J Biol Macromol; 2024 Apr; 264(Pt 1):130351. PubMed ID: 38403231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of O-GlcNAcylation in innate immunity and inflammation.
    Wang Y; Fang X; Wang S; Wang B; Chu F; Tian Z; Zhang L; Zhou F
    J Mol Cell Biol; 2023 Feb; 14(9):. PubMed ID: 36473120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
    Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
    Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting O-GlcNAcylation in cancer therapeutic resistance: The sugar Saga continues.
    Chen L; Hu M; Chen L; Peng Y; Zhang C; Wang X; Li X; Yao Y; Song Q; Li J; Pei H
    Cancer Lett; 2024 Apr; 588():216742. PubMed ID: 38401884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-Step Enzymatic Labeling Reveals a Critical Role of O-GlcNAcylation in Cell-Cycle Progression and DNA Damage Response.
    Tian Y; Zhu Q; Sun Z; Geng D; Lin B; Su X; He J; Guo M; Xu H; Zhao Y; Qin W; Wang PG; Wen L; Yi W
    Angew Chem Int Ed Engl; 2021 Dec; 60(50):26128-26135. PubMed ID: 34590401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation Affects the Pathway Choice of DNA Double-Strand Break Repair.
    Averbek S; Jakob B; Durante M; Averbeck NB
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrient-Driven O-GlcNAcylation Controls DNA Damage Repair Signaling and Stem/Progenitor Cell Homeostasis.
    Na HJ; Akan I; Abramowitz LK; Hanover JA
    Cell Rep; 2020 May; 31(6):107632. PubMed ID: 32402277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-PKcs Ser2056 auto-phosphorylation is affected by an O-GlcNAcylation/phosphorylation interplay.
    Lafont F; Fleury F; Benhelli-Mokrani H
    Biochim Biophys Acta Gen Subj; 2020 Dec; 1864(12):129705. PubMed ID: 32805318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OGT mediated histone H2B S112 GlcNAcylation regulates DNA damage response.
    Wang P; Peng C; Liu X; Liu H; Chen Y; Zheng L; Han B; Pei H
    J Genet Genomics; 2015 Sep; 42(9):467-75. PubMed ID: 26408091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation in cancer development and immunotherapy.
    He XF; Hu X; Wen GJ; Wang Z; Lin WJ
    Cancer Lett; 2023 Jul; 566():216258. PubMed ID: 37279852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation and Its Role in Cancer-Associated Inflammation.
    Ouyang M; Yu C; Deng X; Zhang Y; Zhang X; Duan F
    Front Immunol; 2022; 13():861559. PubMed ID: 35432358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAcylation of amyloid-β precursor protein at threonine 576 residue regulates trafficking and processing.
    Chun YS; Kwon OH; Chung S
    Biochem Biophys Res Commun; 2017 Aug; 490(2):486-491. PubMed ID: 28624365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrient-sensitive protein O-GlcNAcylation shapes daily biological rhythms.
    Liu X; Chiu JC
    Open Biol; 2022 Sep; 12(9):220215. PubMed ID: 36099933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting O-GlcNAcylation to develop novel therapeutics.
    Zhu Y; Hart GW
    Mol Aspects Med; 2021 Jun; 79():100885. PubMed ID: 32736806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential coordination role between O-GlcNAcylation and epigenetics.
    Wu D; Cai Y; Jin J
    Protein Cell; 2017 Oct; 8(10):713-723. PubMed ID: 28488246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation.
    Wang Z; Pandey A; Hart GW
    Mol Cell Proteomics; 2007 Aug; 6(8):1365-79. PubMed ID: 17507370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.
    Lu Q; Zhang X; Liang T; Bai X
    Mol Med; 2022 Sep; 28(1):115. PubMed ID: 36104770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.